Company intelligence / Profile preview

InsuLine Medical

Israel

Ownership: Private
Development stage: Commercial

Overview

InsuLine Medical develops disposable medical devices designed to improve the performance of current insulin treatment methods by optimizing the physiological absorption of insulin. Their technology aims to enhance the efficacy of insulin therapy for diabetes patients[2][4][5].

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Received funding from Israel's Chief Scientistno major pharma/biotech partnerships publicly listed

Beyond the preview

Go deeper on InsuLine Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InsuLine Medical.

Explore the full profile